Infusions and Special Medicines Board Expert Panel Working Group – Call for applications

At the national Quality Assurance and Technical Services symposium on the 9th of November we announced the launch of an Expert Panel to provide the governance and assurance for the product standardisation agenda.

This group will consist of professionals from a wide range of backgrounds, and we’d like to encourage as many people as possible to apply. It will initially meet to agree terms of reference and establish a work pattern. Members will then review and comment on the specifications, prompting a review of the documents before they are published for a public consultation. Once the consultation ends and any final alterations have been made the members will review once more before the official publication of the specifications.

This initial phase is focusing on chemotherapy agents and we will be looking for clinical specialists in that area. These specialists will rotate in and out of the group as we expand the project to cover other classes of medicines.

Once all existing products have been completed the group will only need to meet and provide this function on an ad-hoc basis as new medicines are marketed and dose banding tables established.

Details of the roles and the panel can be found here:FutureNHS Collaboration Platform – FutureNHS Collaboration Platform  and in the document available at this link https://www.bopa.org.uk/resources/expression-of-interest-slwg-infusions-and-special-medicines-expert-panel-standardisation/

Please circulate to your Trust teams, the deadline for applications is 23:59 25th Nov 2022 and should be done via this Form

Thanks, in advance,

Matt Greening

Senior Pharmacy Professional Advisor – Infusions and Special Medicines Programme

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article